Tuesday, June 7, 2016
VaxAlta Inc. is pleased to announce a new collaboration with the Faculty of Science at the University of Alberta to advance early stage livestock vaccines research.
Tuesday, June 28, 2016
A "Point-of-Care Detection for Patients with Acute Myocardial Infarction" CHALLENGE is being launched in close collaboration with DynaLIFE Dx. Don't delay ... apply today!
BioAlberta and the life sciences Industry is thrilled that Minister Deron Bilous will lead the Alberta delegation to BIO 2016. The convention takes place in San Francisco on June 6-9.
Warren Finlay is awarded the 2016 Charles G. Thiel Award for Outstanding Research and Discovery in Respiratory Drug Delivery.
AITF & AIHS announce new "Alberta Small Business Innovation & Research Initiative" program. This commercialization program provides SMEs with access to the supply chains of large end-users, and de-risks innovative solutions for those end-users.
SolAeroMed announces positive proof of concept data for its lead drug (s-1226) in subjects with mild atopic asthma.
Tuesday, May 31, 2016
Edmonton, May 30, 2016 – KMT Hepatech, Inc., a Canadian biotechnology company offering in vivo research services utilizing theproprietary KMT MouseTM, announced that representatives will be participating in the BIO International Convention.
Allergy-FX™ has fighting properties of quail eggs which reduces symptoms from most common allergies and begins working within 15 minutes.
Metabolomic Technologies Inc. signs exclusive licensing and distribution agreement with U.S. based Atlantic Diagnostic Laboratories LLC.
Circle Cardiovascular Imaging Inc. completes substantial financing round to support international business expansion, March 2016.
Quest PharmaTech’s Subsidiary, ONCOQUEST has signed an agreement with Shenzhen Hepalink Pharmaceutical to fund immunotherapy for treatment of cancer. This will provide additional resources for ONCOQUEST to pursue product development.
Dr. Jackie Shan, co-founder of Afexa Life Sciences and co-creator of COLD-FX, takes a natural product and makes it mainstream. Is Allergy-FX going to prove to be the next big winner?
Announcement: the Alberta Multiple Sclerosis (MS) Collaboration: Piloting the Alberta Neuroscience Collaborative - Supporting MS research and translation.
Exciton Technologies Inc., creator of the patented infection-fighting Silver Oxysalts technology, has made a pivotal turn to profitability through expansion of its license agreement with Crawford Healthcare Ltd.
An Edmonton-based biotech firm, celebrates its 15th birthday by moving into a new production and research facility in the Edmonton Research Park.
Tuesday, February 9, 2016
New animal facility for uPA-SCID mouse model with humanized liver
The Alberta Diabetes Institute - Johnson & Johnson Diabetes Research Fund is a $600,000 partnership between Alberta Diabetes Foundation, Janssen Inc. (Johnson & Johnson) and the Government of Alberta.
BioAlberta CEO Mel Wong says the province's biotech sector has a key role to play as the province seeks to diversify its energy-driven economy.
An Edmonton-based industrial biotechnology company says a new strategic partnership with an Ontario firm will help it find customers and markets for a wider range of products.
NanoSpeed enters into a new multi-year research collaboration with Dynalife Dx to develop new point of care tests to help patients obtain information faster about their health.
Dr. Shan is the keynote speaker who will open the annual two-day conference of WISE - Women In Science and Engineering - a national organization dedicated to promoting women in these fields.
The Consulate General of Canada is pleased to announce the successful partnership with the Chicago Innovation Mentors (CIM) to provide a comprehensive mentoring program for Canadian life science and healthcare entrepreneurs, in 2016.